You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Modified COVID-19 vaccines can avoid ‘lengthy’ clinical studies, says MHRA

Updated COVID-19 vaccines that are modified in response to new variants will not require a brand new approval or ‘lengthy’ clinical studies to receive authorisation, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced.